Literature DB >> 15902529

Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia.

M M van der Eerden1, F Vlaspolder, C S de Graaff, T Groot, H M Jansen, W G Boersma.   

Abstract

In a prospective study to evaluate the diagnostic yield of different microbiological tests in hospitalised patients with community-acquired pneumonia, material for microbiological investigation was obtained from 262 patients. Clinical samples consisted of the following: sputum for Gram staining, culture, and detection of pneumococcal antigen; blood for culture and serological tests; urine for detection of Legionella pneumophila serogroup 1 antigen and pneumococcal antigen; and specimens obtained by fiberoptic bronchoscopy. A pathogen was identified in 158 (60%) patients, with Streptococcus pneumoniae (n=97) being the most common causative agent of community-acquired pneumonia. In 82% of the 44 patients with an adequate sputum specimen, a positive Gram stain was confirmed by positive sputum culture. S. pneumoniae infections were detected principally when adequate sputum specimens were examined by Gram stain and culture and when adequate and inadequate sputum specimens were tested for the presence of pneumococcal antigen (n=58; 60%). The urinary pneumococcal antigen test was the most valuable single test for detection of S. pneumoniae infections (n=52; 54%) when sputum pneumococcal antigen determination was not performed. Fiberoptic bronchoscopy was of additive diagnostic value in 49% of the patients who did not expectorate sputum and in 52% of those in whom treatment failed. Investigation of sputum by a combination of Gram stain, culture, and detection of pneumococcal antigen was the most useful means of establishing an aetiological diagnosis of community-acquired pneumonia, followed by testing of urine for pneumococcal antigen. Fiberoptic bronchoscopy may be of additional value when treatment failure occurs.

Entities:  

Mesh:

Year:  2005        PMID: 15902529     DOI: 10.1007/s10096-005-1316-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  38 in total

1.  Diagnostic value of Gram stain and culture of sputum and endotracheal aspirates in bacteremic pneumococcal pneumonia.

Authors:  Christian Chuard; L. Barth Reller
Journal:  Clin Microbiol Infect       Date:  1999-02       Impact factor: 8.067

2.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

3.  Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples.

Authors:  J Domínguez; N Galí; S Blanco; P Pedroso; C Prat; L Matas; V Ausina
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 4.  Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint.

Authors:  G W Waterer; V S Baselski; R G Wunderink
Journal:  Am J Med       Date:  2001-01       Impact factor: 4.965

5.  The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia.

Authors:  G W Waterer; S G Jennings; R G Wunderink
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

6.  Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia.

Authors:  D R Murdoch; R T Laing; G D Mills; N C Karalus; G I Town; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 7.  Limitations of diagnostic testing in the initial management of patients with community-acquired pneumonia.

Authors:  G S San Pedro; G D Campbell
Journal:  Semin Respir Infect       Date:  1997-12

8.  Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation.

Authors:  Michael D Smith; Petra Derrington; Rachel Evans; Marjorie Creek; Rhonwen Morris; David A B Dance; Keith Cartwright
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks.

Authors:  N P Chalasani; M A Valdecanas; A K Gopal; J E McGowan; R L Jurado
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

10.  Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program.

Authors:  Kelley A Gordon; Douglas J Biedenbach; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2003-08       Impact factor: 2.803

View more
  54 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Identification of bacterial pathogens in pediatric community-acquired lower respiratory tract infection using a simplified procedure of sputum sampling and examination: comparison between hospitalized children with and without underlying diseases.

Authors:  T Hoshina; K Kusuhara; T Takimoto; M Saito; T Hara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-24       Impact factor: 3.267

3.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

4.  Are oropharyngeal swabs suitable as samples for Legionella-specific PCR testing?

Authors:  Bram M W Diederen; Marcel F Peeters
Journal:  J Clin Microbiol       Date:  2007-10       Impact factor: 5.948

Review 5.  Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections.

Authors:  K Loens; L Van Heirstraeten; S Malhotra-Kumar; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

6.  Duration of Stay of Patients with Community-Acquired Pneumonia in Influenza Season.

Authors:  Emel Tellioğlu; Günseli Balcı; Aydan Mertoğlu
Journal:  Turk Thorac J       Date:  2018-06-12

Review 7.  The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis.

Authors:  M H Rozenbaum; P Pechlivanoglou; T S van der Werf; J R Lo-Ten-Foe; M J Postma; E Hak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-14       Impact factor: 3.267

8.  Serum vascular endothelial growth factor in pediatric patients with community-acquired pneumonia and pleural effusion.

Authors:  Seong Hwan Choi; Eun Young Park; Hye Lim Jung; Jae Won Shim; Deok Soo Kim; Moon Soo Park; Jung Yeon Shim
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

9.  Syndromic surveillance for local outbreaks of lower-respiratory infections: would it work?

Authors:  Cees C van den Wijngaard; Liselotte van Asten; Wilfrid van Pelt; Gerda Doornbos; Nico J D Nagelkerke; Gé A Donker; Wim van der Hoek; Marion P G Koopmans
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

10.  Antibiotic use in Thailand: quantifying impact on blood culture yield and estimates of pneumococcal bacteremia incidence.

Authors:  Julia Rhodes; Joseph A Hyder; Leonard F Peruski; Cindy Fisher; Possawat Jorakate; Anek Kaewpan; Surang Dejsirilert; Somsak Thamthitiwat; Sonja J Olsen; Scott F Dowell; Somrak Chantra; Kittisak Tanwisaid; Susan A Maloney; Henry C Baggett
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.